Insmed's blood pressure drug meets main goal in mid-stage trial
10/06/2025 12:12
June 10 (Reuters) - Insmed INSM.O said on Tuesday that its experimental blood pressure drug met the main goals in a mid-stage study. (Reporting by Kamal Choudhury in Bengaluru; Editing by Maju Samuel) ((Kamal.Choudhury@thomsonreuters.com;))
Recent news on Insmed
See all newsAstera Labs, CoreWeave and others rise after Nasdaq-100 inclusion
U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle
U.S. RESEARCH ROUNDUP- Adobe, Allstate, Teleflex
Brief: Insmed Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- CAVA Group, Eagle Materials, Vertiv Holdings